Curcuminoids for the treatment of chronic psoriasis vulgaris

Journal of Drugs in Dermatology, Oct, 2007

Sponsored by University of Pennsylvania. The purpose of this study is to determine the safety and to estimate the efficacy of oral Curcuminoid C3 Complex[R] in patients with chronic psoriasis vulgaris.

Condition  Intervention                   Phase

Psoriasis  Drug: Curcuminoids C3 Complex  Phase II

Study ID Numbers: 803489

ClinicalTrials.gov Identifier: NCT00235625

COPYRIGHT 2007 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2007 Gale Group

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement

Content provided in partnership with Thompson Gale